Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2018

May 24, 2018

32853_dirs_2018-05-24_8b7277d9-8ac9-4484-8148-faa596a22017.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2018-05-14

Reporting Person: Kreger Bradley Allen (SVP, Global Operations)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $ Common Stock (50000.0) Direct
Employee Stock Option (Right to Buy) $5.46 2028-05-08 Common Stock (100000.0) Direct

Footnotes

F1: 12/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2019, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to the Reporting Person's continued status as a Service Provider (as defined in the Company's 2017 Inducement Award Plan) through the applicable vest date.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.

F3: 25% of the total number of shares subject to the Option will vest on April 2, 2019 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on April 2, 2022, subject to the Reporting Person's continued status as a Service Provider (as defined in the Company's 2017 Inducement Award Plan) through each applicable vest date.